VYVGART DIN 02541599
Status: Marketed
Holder: ARGENX BV
Health Canada record
| Active ingredient(s) | EFGARTIGIMOD ALFA 20 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | SCHEDULE D; PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L04AL01 EFGARTIGIMOD ALFA |
|---|
| Original market date | 06-Nov-2023 |
|---|
| Current status date | 06-Nov-2023 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EFGARTIGIMOD ALFA
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02562634 | VYVGART SC | ARGENX BV | Solution | EFGARTIGIMOD ALFA 200 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 31686 | 2023-09-19 | New Drug Submission (NDS) | |
Request a quote for VYVGART
How to read a Canadian DIN record